We are live on ! Find out more
ONC

BeOne Medicines Ltd

266 hedge funds and large institutions have $19.1B invested in BeOne Medicines Ltd in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 109 increasing their positions, 77 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 17

42% more repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 77

6% more funds holding

Funds holding: 251266 (+15)

0.12% less ownership

Funds ownership: 4.77%4.65% (-0.12%)

2% less capital invested

Capital invested by funds: $19.5B → $19.1B (-$455M)

8% less funds holding in top 10

Funds holding in top 10: 1211 (-1)

11% less call options, than puts

Call options by funds: $10.2M | Put options by funds: $11.4M

Holders
266
Holders Change
+15
Holders Change %
+5.98%
% of All Funds
4.63%
Holding in Top 10
11
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-8.33%
% of All Funds
0.19%
New
34
Increased
109
Reduced
77
Closed
17
Calls
$10.2M
Puts
$11.4M
Net Calls
-$1.27M
Net Calls Change
+$58M
Name Holding Trade Value Shares
Change
Change in
Stake
E
151
Ergoteles
New York
$1.18M -$4.61M -13,904 -80%
Public Employees Retirement Association of Colorado
152
Public Employees Retirement Association of Colorado
Colorado
$1.15M
Ensign Peak Advisors
153
Ensign Peak Advisors
Utah
$1.13M +$66.2K +200 +6%
Susquehanna International Group
154
Susquehanna International Group
Pennsylvania
$1.12M +$891K +2,691 +462%
Nomura Asset Management
155
Nomura Asset Management
Japan
$1.12M -$47.9M -144,713 -98%
SAM
156
Sabadell Asset Management
Spain
$1.06M +$1.02M +3,081 New
California State Teachers Retirement System (CalSTRS)
157
California State Teachers Retirement System (CalSTRS)
California
$1.05M +$1.01M +3,062 New
Lazard Asset Management
158
Lazard Asset Management
New York
$1.05M +$1.01M +3,055 New
American Century Companies
159
American Century Companies
Missouri
$1.03M +$72.5K +219 +8%
UCFA
160
United Capital Financial Advisors
Texas
$972K +$46.7K +141 +5%
FA
161
FDx Advisors
Illinois
$970K -$15.9K -48 -2%
DILIC
162
Dai-ichi Life Insurance Company
Japan
$961K -$66.2K -200 -7%
Russell Investments Group
163
Russell Investments Group
United Kingdom
$932K -$425K -1,282 -32%
MML Investors Services
164
MML Investors Services
Massachusetts
$860K +$126K +380 +18%
AAF
165
Andra AP-fonden
Sweden
$858K -$2.95M -8,900 -78%
BCV
166
Banque Cantonale Vaudoise
Switzerland
$821K -$4.31K -13 -0.5%
ACI
167
AMP Capital Investors
Australia
$810K
HS
168
HighVista Strategies
Massachusetts
$766K
HC
169
Henshaw Capital
Massachusetts
$732K
DZ Bank
170
DZ Bank
Germany
$724K -$490K -1,478 -41%
KAS
171
Kestra Advisory Services
Texas
$702K +$44.1K +133 +7%
TI
172
Trexquant Investment
Connecticut
$698K +$673K +2,033 New
LA
173
LVW Advisors
New York
$660K +$7.29K +22 +1%
QI
174
QS Investors
New York
$618K
LPL Financial
175
LPL Financial
California
$598K +$167K +504 +41%

ONC Hedge Fund Activity: Q2 2021 in Review

266 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q2 2021, worth a combined $19.1B — down 2.3% from $19.5B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ONC positions and 17 closed out — a net gain of 17 holders — while 109 added to existing stakes and 77 trimmed.

The largest buyer was Capital International Investors, adding an estimated $47.2M. The largest seller was Financial Perspectives, cutting an estimated $135M.

  • 266 institutional investors held BeOne Medicines Ltd (ONC) as of Q2 2021, up from 251 in Q1 2021.
  • Funds reported $19.1B of BeOne Medicines Ltd stock for Q2 2021, down 2.3% quarter-over-quarter.
  • 34 funds opened new BeOne Medicines Ltd positions in Q2 2021 and 17 closed out, a net change of +17 holders.
  • The largest BeOne Medicines Ltd buyer in Q2 2021 was Capital International Investors, an estimated $47.2M added.
  • The largest BeOne Medicines Ltd seller in Q2 2021 was Financial Perspectives, an estimated $135M sold.

Based on aggregated 13F filings for Q2 2021.